Back to Search
JYOTI CHAKRAVARTY, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1740286236Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
35040779(OH)
Research & Publications (13)
Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.
PMID 19663597·Clin Infect Dis·2009
2-rct
Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis.
PMID 19407109·Am J Trop Med Hyg·2009
3-trial
Evaluation of leishmanin skin test in Indian visceral leishmaniasis.
PMID 19346376·Am J Trop Med Hyg·2009
8-other
New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
PMID 18781879·Clin Infect Dis·2008
2-rct
Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar.
PMID 18664241·Trop Med Int Health·2008
3-trial
Correlation between clinical features and degree of immunosuppression in HIV infected children.
PMID 18310794·Indian Pediatr·2008
8-other
Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
PMID 17682988·Clin Infect Dis·2007
4-observational
Study on clinico-epidemiological profile of HIV patients in eastern India.
PMID 17249252·J Assoc Physicians India·2006
8-other
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
PMID 16857807·Clin Cancer Res·2006
7-preclinical
Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody.
PMID 16390983·J Clin Microbiol·2006
4-observational
Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
PMID 16325873·Trans R Soc Trop Med Hyg·2006
5-case
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
PMID 15183116·Biochem Pharmacol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3140 W CENTRAL AVE
TOLEDO, OH 43606 - Phone
- (419) 537-5111
Quick Facts
- NPI
- 1740286236
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile